Office of Research
Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)
The goal of the Pediatric Clinical Pharmacology Research Career Development Program is to promote rigorous career development experiences and inspire innovative research in support of pediatric drug development, with specific focuses in the following groups: neonates, infants, developing children, adolescents, and the transition to adulthood. This will be accomplished by supporting research career development of new faculty-level clinical pharmacologists. These K12 Program grant awards will generate well-qualified researchers who will help meet the need for highly skilled clinical pharmacologist investigators who can take advantage of new technologies and respond to the increasing demands of pediatric clinical pharmacology research. The Pediatric Clinical Pharmacology Research Career Development Program will constitute a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution. These K12 programs will augment the existing NICHD Pediatric Clinical and Developmental Pharmacology Training Network (PCDPTN), a collaborative network which allows interdisciplinary training of clinical, translational, and basic investigators who research pediatric therapeutics.
The PCDPTN was formed in response to the Best Pharmaceuticals for Children (BPCA) Act legislative mandate, requiring pediatric clinical pharmacologists to be included in existent NIH career development programs. This collaborative network—which allows interdisciplinary collaboration of clinical, translational, and basic investigators who research pediatric therapeutics-is demonstrated resource for training and mentorship opportunities. To ensure a diverse pool of highly trained independent clinical pharmacologists, intensive, expanding, supervised career development experiences are necessary. The K12 programs will run in parallel with the existing T32 Pediatric Clinical Pharmacology Postdoctoral Training program leveraging resources offered by existing programs (i.e., Maternal and Pediatrics Precision in Therapeutics (MPRINT) Hub, Pediatric Trials Network (PTN), Maternal Fetal Medicine Units (MFMU) Network, Neonatal Research Network (NRN)) and other NICHD/NIH programs. The pediatric clinical pharmacology training and career development programs, together, intend to address NICHD’s aspirational goals of established the next generation of scientists to harness the techniques necessary for future investigation.
Application Instructions
Please submit:
- A one‐page letter of intent with a description of proposed aims and approach
- If the final application requires a diversity statement or statement of broader impacts, please summarize your plans to address the specific requirements on an additional page.
- CV (not biosketch) of the PI
to limitedsubs@uw.edu by 5:00 PM Wednesday, 11/2/2022. Proposals are due to the sponsor 12/6/2022, so you will need to have your materials in to the Office of Sponsored Programs by 11/23/2022 if given the go‐ahead by the review committee.
Inquiries and Contact Information
Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.
For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.